FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Docetaxel Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Teva Pharmaceuticals (New 03/31/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
20 mg/mL (NDC 45963-790-56) 03/31/2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English